Literature DB >> 14680088

Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.

P M Gustafsson1, P Aurora, A Lindblad.   

Abstract

Many children with cystic fibrosis (CF), receiving modern, aggressive CF care, have normal spirometry results. This study aimed to see if homogeneity of ventilation distribution is impaired early in the course of CF lung disease, and if ventilation inhomogeneity is a more frequent finding than abnormal spirometry in children benefiting from modern CF care. The study compared spirometry findings to two indices of ventilation inhomogeneity (mixing ratio (MR) and lung clearance index (LCI)) from multiple-breath inert gas washout in 43 children with CF, aged 3-18 yrs, and 28 healthy children. In total, 10/43 CF subjects (23%) had reduced forced expiratory volume in one second (FEV1) and 14/34 (41%) showed abnormal maximum expiratory flow at 25% of forced vital capacity (MEF25). In contrast, MR was abnormal in 31/43 (72%) and LCI in 27/43 (63%). MR was abnormal in 22/33 CF subjects with normal FEV1, versus 0/28 controls (p<0.001), and abnormal MR was found in 10/20 CF subjects with normal MEF25, versus 0/22 controls (p<0.001). Nine of the 10 CF subjects with reduced FEV1 and 12/14 with abnormal MEF25 showed abnormal MR. Inert gas washout discloses airway dysfunction in the majority of children with cystic fibrosis with normal lung function judged by spirometry. These findings suggest that multiple-breath inert gas washout is of greater value than spirometry in detecting early cystic fibrosis lung disease.

Entities:  

Mesh:

Year:  2003        PMID: 14680088     DOI: 10.1183/09031936.03.00049502

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  51 in total

1.  Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values.

Authors:  Angela Zacharasiewicz; Sabine Renner; Flora Haderer; Michael Weber; Eleonore Dehlink; Zsolt Szepfalusi; Thomas Frischer
Journal:  Wien Klin Wochenschr       Date:  2017-03-09       Impact factor: 1.704

2.  Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis.

Authors:  E Hatziagorou; V Avramidou; F Kirvassilis; J Tsanakas
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 3.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

4.  Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.

Authors:  P A de Jong; A Lindblad; L Rubin; W C J Hop; J C de Jongste; M Brink; H A W M Tiddens
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

5.  Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.

Authors:  Padmaja Subbarao; Carlos Milla; Paul Aurora; Jane C Davies; Stephanie D Davis; Graham L Hall; Sonya Heltshe; Philipp Latzin; Anders Lindblad; Jessica E Pittman; Paul D Robinson; Margaret Rosenfeld; Florian Singer; Tim D Starner; Felix Ratjen; Wayne Morgan
Journal:  Ann Am Thorac Soc       Date:  2015-06

6.  Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.

Authors:  Franziska M Gisler; Thomas von Kanel; Richard Kraemer; André Schaller; Sabina Gallati
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

7.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

8.  Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Authors:  Padmaja Subbarao; Sanja Stanojevic; Meghan Brown; Renee Jensen; Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Per Gustafsson; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

9.  Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis.

Authors:  Richard Kraemer; Philipp Latzin; Isabelle Pramana; Pietro Ballinari; Sabina Gallati; Urs Frey
Journal:  Respir Res       Date:  2009-11-12

10.  Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.

Authors:  Jinghua Liu; Nancy M Walker; Akifumi Ootani; Ashlee M Strubberg; Lane L Clarke
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.